The COVID-19 Vaccine and the Future of International Laws in Business, Travel, and Trade

Authors

Keywords:

COVID, Doha declaration, intellectual property, travel, international business, trade, international law

Abstract

Since COVID-19, the world has been constantly evolving to adapt. Finding a cure quickly became the focus worldwide which altered set approaches to intellectual property rights. Additionally, creating a controversial vaccine has led to several more questions for the future. With varying vaccines and standards throughout the world, travel, business, and trade may face new challenges which change the current systems.

Downloads

Download data is not yet available.

Author Biography

  • Melanie Lane, Pepperdine University

    J. D. Candidate, Pepperdine Caruso School of Law, Pepperdine University, 24255 Pacific Coast Hwy, Malibu, CA 90263, USA

References

Downloads

Published

2021-08-09

Issue

Vol. 8 No. 2 (2021): May - August Issue

Section

Law Reviews

License

This journal operates under a hybrid access model. Published articles may be available through paid access or subscription, while selected articles may be published as Open Access upon payment of an Open Access fee.

For non-Open Access articles, all rights are reserved by the publisher. No part of these publications may be reproduced, distributed, stored, or transmitted in any form or by any means without prior written permission from the publisher, except for brief scholarly citation and referencing.

Open Access articles, when applicable, are distributed under the specific Creative Commons license indicated on the individual article page.

How to Cite

Lane, M. (2021). The COVID-19 Vaccine and the Future of International Laws in Business, Travel, and Trade. American Journal of Trade & Policy, 8(2), 183-198. https://ajtp.us/article/view/564